Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.

Epilepsies are characterised by abnormal electrophysiological activity of the brain. Among various types of inherited epilepsies different epilepsy syndromes, among them progressive myoclonus epilepsies with features of ataxia and neurodegeneration, are counted. The progressive myoclonus epilepsy of...

Full description

Bibliographic Details
Main Authors: Mira ePolajnar, Slavko eČeru, Nataša eKopitar-Jerala, Eva eŽerovnik
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-08-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnmol.2012.00088/full
_version_ 1818862758301532160
author Mira ePolajnar
Slavko eČeru
Slavko eČeru
Nataša eKopitar-Jerala
Eva eŽerovnik
Eva eŽerovnik
author_facet Mira ePolajnar
Slavko eČeru
Slavko eČeru
Nataša eKopitar-Jerala
Eva eŽerovnik
Eva eŽerovnik
author_sort Mira ePolajnar
collection DOAJ
description Epilepsies are characterised by abnormal electrophysiological activity of the brain. Among various types of inherited epilepsies different epilepsy syndromes, among them progressive myoclonus epilepsies with features of ataxia and neurodegeneration, are counted. The progressive myoclonus epilepsy of type 1 (EPM1), also known as Unverricht-Lundborg disease presents with features of cerebellar atrophy and increased oxidative stress. It has been found that EPM1 is caused by mutations in human cystatin B gene (human stefin B). We first describe the role of protein aggregation in other neurodegenerative conditions. Protein aggregates appear intraneurally but are also excreted, such as is the case with senile plaques of amyloid- β (Aβ) that accumulate in the brain parenchyma and vessel walls. A common characteristic of such diseases is the change of the protein conformation towards β secondary structure that accounts for the strong tendency of such proteins to aggregate and form amyloid fibrils. Second, we describe the patho-physiology of EPM1 and the normal and aberrant roles of stefin B in a mouse model of the disease. Furthermore, we discuss how the increased protein aggregation observed with some of the mutants of human stefin B may relate to the neurodegeneration that occurs in rare EPM1 patients. Our hypothesis (Ceru et al., 2005) states that some of the EPM1 mutants of human stefin B may undergo aggregation in neural cells, thus gaining additional toxic function (apart from loss of normal function). Our in vitro experiments thus far have confirmed that 4 mutants undergo increased aggregation relative to the wild-type protein. It has been shown that the R68X mutant forms amyloid-fibrils very rapidly, even at neutral pH and forms perinuclear inclusions, whereas the G4R mutant exhibits a prolonged lag phase, during which the toxic prefibrillar aggregates accumulate and are scattered more diffusely over the cytoplasm. Initial experiments on the G50E and Q71P missense
first_indexed 2024-12-19T10:04:57Z
format Article
id doaj.art-3e4f26e07f7e4fb5bb57d41006492558
institution Directory Open Access Journal
issn 1662-5099
language English
last_indexed 2024-12-19T10:04:57Z
publishDate 2012-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Neuroscience
spelling doaj.art-3e4f26e07f7e4fb5bb57d410064925582022-12-21T20:26:31ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992012-08-01510.3389/fnmol.2012.0008827371Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.Mira ePolajnar0Slavko eČeru1Slavko eČeru2Nataša eKopitar-Jerala3Eva eŽerovnik4Eva eŽerovnik5Jožef Stefan InstituteJožef Stefan InstituteEN-FIST Centre of excellenceJožef Stefan InstituteJožef Stefan InstituteJožef Stefan International Postgraduate School (IPS)Epilepsies are characterised by abnormal electrophysiological activity of the brain. Among various types of inherited epilepsies different epilepsy syndromes, among them progressive myoclonus epilepsies with features of ataxia and neurodegeneration, are counted. The progressive myoclonus epilepsy of type 1 (EPM1), also known as Unverricht-Lundborg disease presents with features of cerebellar atrophy and increased oxidative stress. It has been found that EPM1 is caused by mutations in human cystatin B gene (human stefin B). We first describe the role of protein aggregation in other neurodegenerative conditions. Protein aggregates appear intraneurally but are also excreted, such as is the case with senile plaques of amyloid- β (Aβ) that accumulate in the brain parenchyma and vessel walls. A common characteristic of such diseases is the change of the protein conformation towards β secondary structure that accounts for the strong tendency of such proteins to aggregate and form amyloid fibrils. Second, we describe the patho-physiology of EPM1 and the normal and aberrant roles of stefin B in a mouse model of the disease. Furthermore, we discuss how the increased protein aggregation observed with some of the mutants of human stefin B may relate to the neurodegeneration that occurs in rare EPM1 patients. Our hypothesis (Ceru et al., 2005) states that some of the EPM1 mutants of human stefin B may undergo aggregation in neural cells, thus gaining additional toxic function (apart from loss of normal function). Our in vitro experiments thus far have confirmed that 4 mutants undergo increased aggregation relative to the wild-type protein. It has been shown that the R68X mutant forms amyloid-fibrils very rapidly, even at neutral pH and forms perinuclear inclusions, whereas the G4R mutant exhibits a prolonged lag phase, during which the toxic prefibrillar aggregates accumulate and are scattered more diffusely over the cytoplasm. Initial experiments on the G50E and Q71P missensehttp://journal.frontiersin.org/Journal/10.3389/fnmol.2012.00088/fullAmyloidCystatin BAggregationneurodegenerationprotein aggregationEPM1
spellingShingle Mira ePolajnar
Slavko eČeru
Slavko eČeru
Nataša eKopitar-Jerala
Eva eŽerovnik
Eva eŽerovnik
Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.
Frontiers in Molecular Neuroscience
Amyloid
Cystatin B
Aggregation
neurodegeneration
protein aggregation
EPM1
title Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.
title_full Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.
title_fullStr Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.
title_full_unstemmed Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.
title_short Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.
title_sort human stefin b normal and patho physiological role molecular and cellular aspects of amyloid type aggregation of certain epm1 mutants
topic Amyloid
Cystatin B
Aggregation
neurodegeneration
protein aggregation
EPM1
url http://journal.frontiersin.org/Journal/10.3389/fnmol.2012.00088/full
work_keys_str_mv AT miraepolajnar humanstefinbnormalandpathophysiologicalrolemolecularandcellularaspectsofamyloidtypeaggregationofcertainepm1mutants
AT slavkoeceru humanstefinbnormalandpathophysiologicalrolemolecularandcellularaspectsofamyloidtypeaggregationofcertainepm1mutants
AT slavkoeceru humanstefinbnormalandpathophysiologicalrolemolecularandcellularaspectsofamyloidtypeaggregationofcertainepm1mutants
AT natasaekopitarjerala humanstefinbnormalandpathophysiologicalrolemolecularandcellularaspectsofamyloidtypeaggregationofcertainepm1mutants
AT evaezerovnik humanstefinbnormalandpathophysiologicalrolemolecularandcellularaspectsofamyloidtypeaggregationofcertainepm1mutants
AT evaezerovnik humanstefinbnormalandpathophysiologicalrolemolecularandcellularaspectsofamyloidtypeaggregationofcertainepm1mutants